Biomarkers for epicardial adipose tissue
AssigneeSociete des Produits Nestle S.A.
InventorsFiona Camille Beguelin, Sebastiano Collino, Françios-Pierre Martin, Ivan Montoliu Roura, Max Scherer
Life of this patent
Estimating the term…
Loading patent…
AssigneeSociete des Produits Nestle S.A.
InventorsFiona Camille Beguelin, Sebastiano Collino, Françios-Pierre Martin, Ivan Montoliu Roura, Max Scherer
Estimating the term…
A method for predicting the level of epicardial adipose tissue (EAT) in a subject comprising: (a) determining a level of one or more lipid biomarkers in a sample from the subject, wherein the biomarkers are selected from the following: (i) phosphatidylcholine (PC) [16:1/16:1] (ii) diacylglycerol (DAG) [42:8] (iii) phosphatidylethanolamine-ether (PE-O) [32:5] (iv) phosphatidylcholine (PC) [18:0/22:5] (v) phosphatidylinositol (PI) [18:0/16:1] (vi) phosphatidylglycerol (PG) [20:3/20:3] (vii) phosphatidylglycerol (PG) [22:5/18:1] (b) comparing the levels of the biomarkers in the sample to reference values; wherein the levels of the biomarkers in the sample compared to the reference values are indicative of levels of EAT fat in the subject.
A method of promoting healthy levels of epicardial adipose tissue (EAT) in a subject, the method comprising:
Dependencies are inferred from the claim text.